Oppenheimer downgraded Opthea (OPT) to Perform from Outperform.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OPT:
- Opthea downgraded to Neutral from Buy at H.C. Wainwright
- CoreWeave initiated, Carvana upgraded: Wall Street’s top analyst calls
- Hold Rating Issued for Opthea Limited Amid Uncertainty Following Phase 3 Trial Failure
- Opthea Limited: Hold Rating Amid Phase 3 Trial Failure and Financial Uncertainty
- Opthea’s COAST Phase 3 Trial Fails to Meet Primary Endpoint, Raising Financial Concerns